The objectives of this study are to find the percentage of depressive symptoms and the most appeared clinical manifestation of depressive symptoms. A total of 2016 patient with type 2 diabetes from M Djamil General Hospital had fulfilled the questionnaire we administered. Demographic and clinical data were determined from the patient's medical records. Depressive symptoms defined by The Center for Epidemiologic Studies Depression ScaleRevised (CESD-R) score of 16 or higher. CESD-R consisted of nine symptoms group and a 20-item questionnaire. These symptoms groups in patients with depressive symptoms will be counted. Patients with depressive symptoms were grouped based on a type of diabetic medication they consumed (diet only, oral antidiabetic, and insulin) and diabetic complication. From 2016 patients participated in this study, we found 235 (11.7%) patients were having depressive symptoms. The most appeared clinical manifestation in 235 patients with depressive symptoms is fatigue (88.08%), loss of interest (52.34%), sadness (41.7%), poor concentration (40.42%), and agitation (23.83%). There are more depressive symptoms in patients consuming oral antidiabetic drug than patients using insulin and diet only (70.2 vs. 28.1 vs 1.7%). More depressive symptoms are also found in patients with diabetic nephropathy than patients with diabetic neuropathy and heart disease (52.8 vs. 27.7 vs. 19.6%). These findings showed that there are many depressive symptoms in patients with T2DM, and some of most appeared clinical manifestation in depressive symptoms should be considered.
. INTRODUCTION
Depressive symptoms are a frequent co-morbid condition in diabetes. Approximately 30% of diabetes patients report significantly elevated depressive symptoms and one-third of these patients fulfill the diagnostic criteria of a major depressive disorder. The presence of depressive symptoms in T2DM will worsen the achievement of treatment targets, glycemic control, and quality of life. The World Health Organization (WHO) predicted that by the year 2020, depression will take the second rank in global disease burdens, in this case including diabetic patients [1, 2] .
With a population of 237.6 million people in 2010, Indonesia is the world's fourth most populated country. It also has the seventh largest number of diabetic patients (7.6 million), despite relatively low prevalence (4.8% including both diabetes 1 and 2 in individuals aged in 2012. This large number of diabetes in Indonesia will certainly affect the incidence of depressive symptoms. The incidence of diabetes in West Sumatera is 5.7% [3, 4] .
The prevalence of depressive symptoms is higher among people with diabetes compared with the general populations. These associations may be related to increased risk of depressive symptoms in an individual with diabetes. Depressive symptoms are associated with worse outcomes in the natural history of type 2 diabetes mellitus [5] .
The objectives of this study are to find the percentage of depressive symptoms and the most appeared clinical manifestation in depressive symptoms, especially in Padang, West Sumatera, Indonesia. Depressive symptoms in diabetes will decrease the quality of life of diabetic patients because it may lead to poorer outcomes and increased risk of complications by lowering adherence to glucose monitoring, exercise, diet, and İD İD İD medication regimens. Depressive symptoms may also cause additive functional impairment and lead to increased costs and utilization of health care in diabetic populations.
RESULTS

Baseline Characteristics
A total of 2016 patient participated in this study. Female patients were 1133 (56.2%) and male patients were 883 (43.8%). Less than 50 years old was 582 (28.9%), and more than 50 years old were 1434 (71.1%). Patients having type 2 diabetes for less than 5 years were 1051 (52.1%), more than 5 years were 965 (47.9%), obese 457 (22.7%), hypertension 1014 (50.3%), hypertriglyceridemia 798 (39,6%), and hypo high density lipoprotein 884 (43.8%).
Based on their medication, 1027 (42.3%) patients used oral antidiabetic drugs, 722 (31.7%) used insulin, and 267 (13.2%) patients used diet modification. The most common complication is neuropathy 1256 (62.3%), heart disease 1021 (50.6%), and diabetic nephropathy 958 (47.5%). We found 235 (11.7%) patients have depressive symptoms. 
Percentage of depressive symptoms in T2DM patients
Clinical manifestation in 235 patients with depressive symptoms
There is nine symptoms group in CESD-R that fulfilled by the patients. From 235 patients with depressive symptoms, we found the most appeared clinical manifestation are fatigue (88.08%), loss of interest (52.34%), sadness (41.7%), poor concentration (40.42%), and agitation (23.83%) ( Table 2) . 
DISCUSSION
The incidence of depressive symptoms in diabetes mellitus in this study was 11.7%. Clinical manifestations of depressive symptoms in patients with type 2 diabetes mellitus (T2DM) in Dr. M. Djamil Hospital are the same as the general population, such as sadness, loss of interest or pleasure, feeling guilty or low self-worth, disturbed sleep or appetite, feeling of tiredness, and poor concentration. Ismail (2017) in his study stated that depressive symptoms are present in 14.1% of patients with diabetes mellitus [5, 6] .
Prevalence of depressive symptoms in diabetic patients in several studies ranges from 15-35%. Mezuk (2008) stated that diabetes mellitus is associated with an increased risk of depression, with a relative risk of 1.15 (95% CI 1.02-1.30). This is confirmed in other studies that stated the risk of depression increases by two to three times in patients with diabetes mellitus [7] [8] [9] .
In this study, we found depressive symptoms were more common in women. This is relevant to previous studies by Sun (2016) and Jacob (2016) . Sun (2016) suggested that sex difference could be due to lifestyle factors. Most of the women in Chinese society, as well as Padang, normally spend most of their time at home, which may lead to lower physical activity and poor eating habits [10, 11] .
Younger patients were more likely to have depressive symptoms in this study. This was a contrast from the previous study that found patients more than 65 years old had a higher risk of developing depressive symptoms. This discrepancy might be a result of patients' denial of diabetic status and diabetes complications possibility that they might have in the next years. [10, 11] In this study, longer diabetes duration was associated with higher depressive symptoms. This finding was consistent with other studies that suggested the longer diabetic duration, the higher number of diabetes complications they could have. Diabetes complications such as neuropathy, nephropathy, and heart disease may increase susceptibility to depressive symptoms. This study also found that there was an association between diabetes comorbid, like obese, hypertension, and dyslipidemia with more depressive symptoms in diabetic patients. Katon (2008) found that patient with comorbidity are 3 times to be nonadherent to treatment recommendation and lack of self-care. Self-care in diabetes includes adherence to dietary restrictions, adequate physical activity, taking medication as prescribed, and blood glucose monitoring [12] .
The most appeared clinical manifestation in a depressive symptoms group is fatigue (88.08%), loss of interest (52.34%), sadness (41.7%), poor concentration (40.42%), and agitation (23.83%). Kalra (2018) suggested that prominent symptoms of fatigue in the majority of patients with depression. Fatigue is often associated with impaired concentration, irritability, and reduced productivity [13] .
In this study, we found that oral antidiabetic group is more than insulin and diet the only group. Previous studies stated that depressive symptoms are found more in people with diabetes who only use an oral antidiabetic drug. The increased amount of antidiabetic drug consumption could have stressed and burdened patient's feelings that causing depressive symptoms. But, we didn't find which oral antidiabetic drug causes more depressive symptoms [14] .
Increased of depressive symptoms in patients using an oral antidiabetic drug also found by Berge (2015) . The possible explanation is that treatment with the oral antidiabetic drug can cause depressive symptoms, but we didn't find any support for this finding. Berge (2015) assume that those with oral antidiabetic drug have a disease that is more difficult to treat. The more oral antidiabetic drug is consumed by patients, the more difficult to control diabetes that they suffered. We assumed that patients consuming oral antidiabetic drug were afraid of negative effect in long-term drug use [15] .
However, Noh (2005) stated that insulin therapy in diabetic patients causes more depressive symptoms than patients who take oral antidiabetic drugs. Meanwhile, Berge (2012) stated that depressive symptoms are more prevalent in a group of patients using a combination of oral antidiabetic drug and insulin [16] [17] [18] .
In this study, we found that patients with diabetic nephropathy are more than diabetic neuropathy and heart disease. The dialysis process and the feelings that this is the end of the disease could increase depressive symptoms. Previous meta-analysis study stated that there is a relationship between depressive symptoms with macrovascular and microvascular complications. Nouwen (2015) stated that depression in diabetes will increase the risk of macrovascular and microvascular complications. Previous studies also stated that there is a link between depressive symptoms and macrovascular complications, which was a myocardial infarction [5, 19, 20] . Yu (2013) found an association between depression with diabetes and chronic kidney disease. Yu suggested that depression is associated with proinflammatory cytokines and this proinflammatory state has been linked with an increased risk of diabetic nephropathy. Takasaki (2016) also found that the progression of diabetic nephropathy is likely to be associated with increased risk and severity of depression [21, 22] .
CONCLUSION
The percentage of depressive symptoms in a patient with type 2 diabetes mellitus is 11.7%. The most appeared clinical manifestation in 235 patients with depressive symptoms is fatigue, loss of interest, sadness, poor concentration, and agitation. There are more depressive symptoms in patients consuming oral antidiabetic drug than patients using insulin and diet only. More depressive symptoms are also found in patients with diabetic nephropathy than patients with diabetic neuropathy and heart disease. These findings showed that there are many depressive symptoms in patients with T2DM, and some of most appeared clinical manifestation in depressive symptoms should be considered.
MATERIALS AND METHODS
We conducted a secondary analysis of data obtained in M Djamil General Hospital Padang, West Sumatera, Indonesia from January 2017 until December 2017. Dr. M. Djamil General Hospital is a type A, national referred hospital for West Sumatera region and an educational hospital. Diabetic patients' referral visit to a diabetic clinic reaches approximately 100 -200 patients per day.
All T2DM outpatients in this hospital were eligible to participate in the study. T2DM was confirmed by fasting blood glucose levels and HbA1c. They have agreed to participate and signed the informed consent form. There are no patients with prediabetic included in this study. Patients with depression history and consuming any antidepressant were excluded. Patients with Severe Cognitive or Language Deficits were excluded. Demographic and clinical data, such as gender, age, duration of diabetes, nutritional status, hypertension status, triglyceridemia profile, high-density lipoprotein profile, type of complications, type of diabetes medications was determined from patient's medical records. We defined nutritional status by calculating body mass index (BMI). BMI more than 25 kg/m 2 defined as obese. Age group divided by 50 years old according to Charlson Comorbidity Index. Triglyceridemia profile and high-density lipoprotein profile are part of dyslipidemia. Ethical approval was granted by the Medical Faculty University of Andalas Research Ethics Committee.
Depressive symptoms were assessed at visit using The Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), a 20-item questionnaire in nine clinical manifestation group developed to assess depressive symptoms in a community population. Van Dam (2011) suggested the CESD-R is an accurate and valid measure of depressive symptoms in the general population [23] . The CESD-R items represent the major components of depression and include depressed mood, feelings of worthlessness, feelings of hopelessness, loss of appetite, poor concentration, and sleep disturbance. Participants were interviewed by internist in the diabetic clinic to rate each item on a scale from 0 to 3 based on "how often you felt this way during the past week." The interview was carried out about 30 minutes. Scores range from 0 to 60, with higher scores indicating more severe depressive symptoms. For the purpose of our analyses, depressive symptoms were defined by a CESD-R score of 16 or higher.
We compared a number of occurrence in patients with depressive symptoms based on demographics, clinical data, type of diabetic medication they consumed (diet only, oral antidiabetic, and insulin) and diabetic complication. We used chi-square analysis to compared variables in this study. The level of statistical significance was 5%. This data analyzed by SPSS 22.0.
